Interleukins
Interleukins - Related Videos
03:33
Evaluating the Effects of Fecal Microbiota Transplantation in an Interleukin-10 Deficient Mouse
0 Views •
2025
This video demonstrates a procedure of fecal microbiota transplantation in an interleukin-10 deficient mouse with colon inflammation. Colonized fecal microbes in the gut release secondary metabolites, eliciting anti-inflammatory cytokine release and reducing colon inflammation.
08:43
Microinjection of Interleukin-6 into the Bloodstream of TSC Zebrafish Larvae to Study Neuropsychiatric Disorder-Like Behaviors
0 Views •
2026
To model how inflammatory signals influence neurodevelopment in genetically susceptible organisms, we present a protocol for microinjecting IL-6 into the duct of Cuvier (common cardinal vein) of zebrafish larvae, enabling controlled induction of inflammation and assessment of its developmental impact in the context of tuberous sclerosis complex (TSC).
05:41
Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
0 Views •
Cited by 6 •
2022
The interaction of genetic susceptibility, mucosal immunity, and intestinal microecological environment is involved in the pathogenesis of inflammatory bowel disease (IBD). In this study, we applied fecal microbiota transplantation to IL-10 deficient mice and investigated its impact on colonic inflammation and heart function.
03:14
Ex Vivo Expansion of Natural Killer Cells from Peripheral Blood Mononuclear Cells
0 Views •
2025
This video demonstrates a technique for the expansion of natural killer (NK) cells directly from peripheral blood mononuclear cells (PBMCs) using a feeder cell line. PBMCs are co-cultured with genetically modified lymphoblastoid feeder cells expressing membrane-bound interleukin-21 (mIL-21), and the culture is supplemented with the cytokines interleukin-2 (IL-2) and interleukin-15 (IL-15). Together, this cocktail of ligands leads to the prolonged expansion of NK cells with high purity.
09:30
Efficient and Rapid Generation of CAR-T and Cytokine-Induced Killer Cells in GMP-scalable Devices
0 Views •
2025
This protocol describes a scalable method for the expansion of Adoptive Cell Therapies (ACT) products, namely Chimeric Antigen Receptor (CAR)-T cells and Cytokine-Induced Killer (CIK) cells, using Gas-permeable Rapid expansion (G-Rex) devices, demonstrating efficient and robust growth in a clinically relevant setting.
FAQs
The response depends on whether a target cell carries the matching receptor. After binding, the receptor initiates intracellular signaling that can alter gene expression and change cellular behavior. Depending on the signaling context, these changes may promote activation, proliferation, differentiation, or migration, allowing the same communication system to coordinate distinct immune and tissue responses.
Intracellular pathways convert an interleukin-receptor interaction into changes inside the target cell. They regulate gene expression, which determines how the cell responds after receiving the signal. This link explains how interleukin communication can influence immune activation, inflammatory processes, tissue repair, and blood cell development rather than producing only a temporary surface-level interaction.
Their effects depend on the responding cell and the signaling processes activated after receptor engagement. The resulting changes may affect cell activation, proliferation, differentiation, or migration, while the broader setting may involve infection, inflammation, tissue repair, or blood cell development. Studying these context-dependent outcomes helps clarify how immune responses are controlled.
Interleukin signaling helps coordinate communication during infection responses and inflammation, while also contributing to tissue repair and immune regulation. This coordination is important because immune activity must be directed toward a biological challenge and controlled within tissues. Disrupted signaling networks can therefore be examined in relation to autoimmune disorders and cancer.
A useful research strategy is to examine the interleukins, their specific receptors, and the intracellular pathways activated after binding. Researchers can then relate signaling changes to effects on gene expression, cell activation, proliferation, differentiation, or migration. This approach connects molecular communication with broader outcomes such as inflammation, infection responses, tissue repair, and blood cell development.
These components provide molecular points for investigating how immune responses become altered in conditions such as autoimmune disorders and cancer. Research can focus on how receptor engagement and downstream signaling change cellular behavior or inflammatory regulation. The same components also support diagnostic research and therapeutic development because they connect measurable signaling events with disease-related biology.